MedPath

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

Not Applicable
Recruiting
Conditions
Cancer
Registration Number
NCT06367959
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

Detailed Description

Primary Objective:

To determine the effects of writing therapy on QOL and perceived stress at the 6- and 12-month follow-ups.

Secondary Objective:

To discover the effects of writing therapy on stress biomarkers and perceived stress at the 3-month follow-up.

To explore the psychosocial and cultural mechanisms responsible for the benefits of writing therapy by using mixed methods.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
192
Inclusion Criteria
  • Adult (aged 18 and older) diagnosed with stage 0-III cancer (or acute leukemia in remission/ chronic myeloid leukemia in chronic phase).
  • Self-identified as Asian, Asian Americans, any Asian or Asian American subgroup (Chinese, Vietnamese, Indian, Korean, etc.) ethnic/cultural background
  • Completed primary treatment, including surgery, chemotherapy, and/or radiation therapy, immunotherapy, or targeted therapy within the preceding 5 years.
  • Comfortable reading in English or in Chinese.
Exclusion Criteria
  • Inability to provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Primary Outcome Measure: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0Time Frame: through study completion; an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MD Anderson Cancer Center

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

MD Anderson Cancer Center
πŸ‡ΊπŸ‡ΈHouston, Texas, United States
Qian Lu, MD, PHD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.